Showing 13,181 - 13,200 results of 132,239 for search '(( a e decrease ) OR ( 5 ((((nn decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 2.16s Refine Results
  1. 13181

    Effects of single-agent vemurafenib on BRAF mutated NSCLC cells. by Monika Joshi (695076)

    Published 2015
    “…V induces cell cycle arrest in HCC364 cells, as evidenced by an increase in G1 and a significant decrease in S phase. …”
  2. 13182

    Table_3_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
  3. 13183

    Table_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
  4. 13184

    Image_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
  5. 13185

    Image_4_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
  6. 13186

    Table_1_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.xlsx by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
  7. 13187

    Image_2_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
  8. 13188

    Image_3_A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.jpg by Sisi Shan (6738692)

    Published 2021
    “…Thus, P36-5D2 represents a new and desirable human antibody against the current and emerging SARS-CoV-2 variants.…”
  9. 13189
  10. 13190

    A Ligand-Based Drug Design. Discovery of 4‑Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2 by Jiawang Liu (1330971)

    Published 2015
    “…With a 5 min preincubation in the presence of NADPH, 0.01 μM 7,8-furanoflavone completely inactivates P450 1A2 but does not influence the activities of P450s 1A1 and 1B1. …”
  11. 13191

    A systematic review of consumer preference for e-cigarette attributes: Flavor, nicotine strength, and type by Samane Zare (4966786)

    Published 2018
    “…E-cigarette users likely initiated use with a cigarette like product and transitioned to an advanced system with more features. …”
  12. 13192
  13. 13193

    Response rate of patients with <i>CYP3A4</i> and <i>CYP3A5</i> polymorphisms after tacrolimus initiation. by Maizumi Furuse (10688237)

    Published 2021
    “…<p>Panel A shows the response rate of patients with <i>CYP3A4</i> polymorphisms at 1, 2, and 4 weeks after Tac treatment, and panel B shows that of patients with <i>CYP3A5</i> polymorphisms. …”
  14. 13194
  15. 13195

    Image_5_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  16. 13196

    Image_5_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

    Published 2022
    “…After inoculation of 10<sup>5</sup> PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”
  17. 13197
  18. 13198
  19. 13199

    Image_5_Creation of Early Flowering Germplasm of Soybean by CRISPR/Cas9 Technology.png by Jianan Han (7911278)

    Published 2019
    “…In addition, no off-target effects were observed by predicting and analyzing the potential off-target sites of E1 targets. Significant decreased E1 gene expression of two novel mutants showed that the truncated E1 protein disinhibited GmFT2a/5a and increasing GmFT2a/5a gene expressions resulted obvious early flowering. …”
  20. 13200

    Mcl-1 degradation is slowed by a T163E mutation (but not T163A) in transfected CHO cells. by Shanna K. Nifoussi (128297)

    Published 2012
    “…A short autoradiographic exposure is also shown because additional bands were detected at the high levels of expression obtained with Mcl-1-T163E. …”